T Cell Memory

joint with B Cell Renaissance: Epigenetics, Regulation and Immunotherapy

Organizer(s): David B. Masopust, Ananda W. Goldrath and Marion Pepper

Sponsored by BioLegend, Inc. and Nektar Therapeutics

For important information on the coronavirus, please click here

Summary of Meeting:

This conference will bring together immunologists with expertise in basic lymphocyte biology, vaccinology, and cancer immunotherapy to discuss the most recent advances in immunological memory. This conference will be paired with B Cell Renaissance: Epigenetics, Regulation and Immunotherapy. There will be one joint session which will focus on B cell memory, and then the remaining sessions will be tilted towards T cell memory and helper T cell responses. The conference program is designed to communicate the paradigm shifting discoveries on the molecular programming and epigenetic maintenance of lymphocyte differentiation states, introduce cutting edge tools to a broad audience, and promote cross-fertilization between diverse scientists to accelerate application of new concepts in immune memory for vaccines that prevent infectious disease or enhance the durability and function of adoptive cell therapies for treating cancer. This conference is very timely due to the recent identification of resident memory lymphocytes that is changing how researchers strategize employing memory for prevention of infectious disease. These latest findings should be shared with the vaccine community. Interest in adoptive cell therapies has exploded, but success will depend on manipulating the durability and differentiation state of transferred cancer-fighting lymphocytes. The field of immunological memory is poised to address these challenges and contribute to clinical advances in leveraging this exciting therapeutic approach. Moreover, perhaps for the first time, this conference will directly attempt to highlight problems and provide a solution to the nomenclature problems that have impeded discourse and advances related to memory T cell ontogeny.

Scholarship Deadline: November 5 2019

Discounted Abstract Deadline: November 5 2019

Abstract Deadline: December 4 2019

Discounted Registration Deadline: January 8 2020

Abstract submission is now closed. Registered attendees may bring a poster onsite. Please contact our office at +1 800-253-0685; +1 970-262-1230 or email info@keystonesymposia.org if you are interested.

Keystone Symposia thanks our Sponsor(s) for generously supporting this meeting:

We gratefully acknowledge additional support for this conference from:

We gratefully acknowledge the generous grant for this conference provided by:

National Institute of Allergy and Infectious Diseases (NIAID)
Grant No. 1R13AI149883-01
Funding for this conference was made possible (in part) by 1R13AI149883-01 from the National Institutes of Health. The views expressed in written conference materials or publications and by speakers and moderators do not necessarily reflect the official policies of the Department of Health and Human Services; nor does mention by trade names, commercial practices, or organizations imply endorsement by the U.S. Government.

We appreciate the organizations that provide Keystone Symposia with additional support, such as marketing and advertising:

Click here to view more of these organizations

Special thanks to the following for their support of Keystone Symposia initiatives to increase participation at this meeting by scientists from underrepresented backgrounds:

Click here to view more of these organizations